Table 4.
Average ΔFEV1 (ml) | Category midpoint value of ΔFEV1 (ml) | TDI at 12 weeks % responders (n = 2781) | TDI at 24/26 weeks % responders (n = 2208) | TDI at 52 weeks % responders (n = 1099) | ΔSGRQ at 12 weeks % responders (n = 3141) | ΔSGRQ at 24/26 weeks % responders (n = 2215) | ΔSGRQ at 52 weeks % responders (n = 1115) |
---|---|---|---|---|---|---|---|
-500, -50 | -275 | 50 | 51 | 45 | 42 | 49 | 41 |
-50, 50 | 0 | 48 | 49 | 53 | 46 | 45 | 45 |
50, 150 | 100 | 54 | 57 | 50 | 48 | 48 | 49 |
150, 250 | 200 | 59 | 60 | 58 | 53 | 59 | 54 |
250, 500 | 375 | 66 | 69 | 69 | 56 | 57 | 65 |
*Responders were patients who achieved at least the minimal clinically important difference (MCID; one and four units for TDI and ΔSGRQ, respectively); TDI, Transition Dyspnoea Index; ΔSGRQ, change from baseline in St George's Respiratory Questionnaire; ΔFEV1, change from baseline in trough forced expiratory volume in 1 second.
†For the outcomes, each row contains approximately 20% of the column's indicated n, as in the left half of Table 2